PAX5 is arguably one of the most important transcription factors required for correct B cell development3, and it can be involved in B-ALL at different stages of the disease, being altered in more than one-third of B-ALL cases by deletion, sequence mutations, or translocation with different fusion partners3–6. The gene discussed is PAX5; the disease is acute lymphoblastic leukemia.